Although no dose-limiting toxicity was observed and CAR T cell persistence was noted up to 12 months post-infusion, no significant survival benefit was noted for treated patients with a median overall survival of 11
Although no dose-limiting toxicity was observed and CAR T cell persistence was noted up to 12 months post-infusion, no significant survival benefit was noted for treated...